181 related articles for article (PubMed ID: 23771732)
1. Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.
Roberts MR; Hong CC; Edge SB; Yao S; Bshara W; Higgins MJ; Freudenheim JL; Ambrosone CB
Breast Cancer Res Treat; 2013 Jun; 139(3):873-85. PubMed ID: 23771732
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
Hsieh SM; Smith RA; Lintell NA; Hunter KW; Griffiths LR
BMC Cancer; 2009 Sep; 9():331. PubMed ID: 19765277
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.
Brooks R; Kizer N; Nguyen L; Jaishuen A; Wanat K; Nugent E; Grigsby P; Allsworth JE; Rader JS
Gynecol Oncol; 2010 Mar; 116(3):539-43. PubMed ID: 19906411
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
Gaudet MM; Hunter K; Pharoah P; Dunning AM; Driver K; Lissowska J; Sherman M; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Int J Cancer; 2009 Apr; 124(7):1716-20. PubMed ID: 19089925
[TBL] [Abstract][Full Text] [Related]
5. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.
Ugenskienė R; Myrzaliyeva D; Jankauskaitė R; Gedminaitė J; Jančiauskienė R; Šepetauskienė E; Juozaitytė E
Biomarkers; 2016; 21(4):363-70. PubMed ID: 26901824
[TBL] [Abstract][Full Text] [Related]
6. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.
Hsieh SM; Look MP; Sieuwerts AM; Foekens JA; Hunter KW
Breast Cancer Res; 2009; 11(5):R75. PubMed ID: 19825179
[TBL] [Abstract][Full Text] [Related]
7. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.
Crawford NP; Ziogas A; Peel DJ; Hess J; Anton-Culver H; Hunter KW
Breast Cancer Res; 2006; 8(2):R16. PubMed ID: 16563182
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
[TBL] [Abstract][Full Text] [Related]
10. Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.
Pei R; Xu Y; Wei Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Front Med; 2013 Mar; 7(1):138-42. PubMed ID: 23358895
[TBL] [Abstract][Full Text] [Related]
11. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.
Yi SM; Li GY
Tumour Biol; 2014 Jan; 35(1):441-5. PubMed ID: 24006220
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
13. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Song Y; Barry WT; Seah DS; Tung NM; Garber JE; Lin NU
Cancer; 2020 Jan; 126(2):271-280. PubMed ID: 31581314
[TBL] [Abstract][Full Text] [Related]
15.
Lin LZ; Cai MG; Dai YC; Zheng ZB; Jiang FF; Shi LL; Pan Y; Song HB
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28533425
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
